Cara Therapeutics, Inc.
Patent Owner
Stats
- 25 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 01, 2018 most recent publication
Details
- 25 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 781 Total Citation Count
- Dec 23, 1997 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0028,594 PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR HARD TISSUE PAINNov 03, 15Feb 01, 18[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0007,574 PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR UREMIC PRURITUS IN DIALYSIS PATIENTSAbandonedJun 27, 16Jan 12, 17[A61K]
2016/0250,277 PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR PREVENTING, INHIBITING OR TREATING NAUSEA AND VOMITINGAbandonedOct 27, 14Sep 01, 16[A61K]
2015/0150,935 PERIPHERAL KAPPA RECEPTOR AGONISTS FOR REDUCING PAIN AND INFLAMMATIONAbandonedJun 05, 13Jun 04, 15[A61K]
2013/0012,431 Method For Elevating Prolactin In MammalsAbandonedJul 06, 12Jan 10, 13[A61K, A61P, A61M]
2010/0105,777 AMIDE OR THIOAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PAINAbandonedFeb 23, 09Apr 29, 10[A61K, C07C, A61P]
7504538 Amide or thioamide derivatives and their use in the treatment of painExpiredOct 14, 04Mar 17, 09[C07C]
2008/0161,340 Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereofAbandonedDec 19, 07Jul 03, 08[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.